DXCM

Q: What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is US$ 65,12, with a variation of -5.91% compared to the last year. The price of DexCom (DXCM) started the year trading around US$ 77,77 and today it is at US$ 65,12. Follow the real-time price chart, the historical price of DexCom (DXCM), and stock data from Ibovespa and international markets.

Q: When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

Q: DexCom (DXCM) is it worth it?

Currently, DexCom (DXCM) is priced at US$ 65,12, with a P/E of 42,62%, representing a deviation of 103,60% from its historical average P/E. In the last year, the stock showed a variation of -5.91% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -5,91%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of DexCom (DXCM)?

Investing in stocks of DexCom (DXCM) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -14,32% in the last month, -5,91% in the last year and -33,92% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of DexCom (DXCM) today, the total investment would be US$ 6.512,00, based on the current price of US$ 65,12.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 6.127,14In 5 years: US$ 4.303,13In 10 years: 24.009,09It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DexCom Inc.

Price

US$ 65,12

variation (12m)

-5,91%

p/l

42,62

p/vp

10,21

DIVIDEND YIELD

0,00%

price DXCM

BVMF

DXCM

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of DXCM

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-14,32%

3 months

-21,89%

1 year

-5,91%

2 years

-13,74%

5 years

-33,92%

10 years

268,69%

real profitability

profitability minus inflation.

1 month

-14,32%

3 months

-22,18%

1 year

-10,04%

2 years

-21,27%

5 years

-51,17%

10 years

120,74%

Indicators DXCM

check out the fundamentals of DexCom shares

P/E

42,62

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

5,89

Sector: 1,95 Industry: 2,78

P/BV

10,21

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

8,42%

Sector: -26,82% Industry: -52,06%

ROE

23,97%

Sector: -29,98% Industry: -40,51%

ROIC

17,95%

Sector: -411,56% Industry: -412,66%

NET MARGIN

13,82%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

58,75%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

16,75%

Sector: -23,36% Industry: -26,70%

P/EBITDA

28,28

Sector: 0,02 Industry: -2,09

P/EBIT

32,60

Sector: -1,26 Industry: -2,90

P/ASSET

3,59

Sector: 1,27 Industry: 1,41

BVPS

6,56

Sector: 3,73 Industry: 1,64

EPS

1,57

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,35

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

17,16%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

2,47%

Sector: - Industry: -

FAIR PRICE OF DexCom ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 65,12

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-76,62%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

DXCM indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%

comparison of DXCM with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History DXCM

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY DexCom

DexCom Inc.

Average user rating I10

4.0 (12 people)

Estados Unidos

26 years

Foundation: 1999

2005

Year of debut on the stock exchange - 20 years

6.400

Employees

The Company DexCom Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 26,28 Billions, having a net worth of $ 2,57 Billions.

With a total of 6.400 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 4,46 Billions, which generated a profit in the amount of $ 616,70 Milhões.

As for its main indicators, the Company has a P/E ratio of 42,62, a P/BV ratio of 10,21 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DXCM.

Market value

US$ 26,28 Billions

Net worth

US$ 2,57 Billions

US$ 2.573.100.000,00

Assets

US$ 7,33 Billions

US$ 7.327.000.000,00

Total Number of Shares

392,00 Milhões

392.000.000

Average Daily Trading Volume

US$ 5,18 Milhões

US$ 5.181.536,02

Sector

Health

Industry

Medical Supplies and Equipment

DXCM

DXCM revenue and profits

DXCM results

DRAG THE FRAME TO SEE MORE DATA

DXCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is US$ 65,12, with a variation of -5.91% compared to the last year. The price of DexCom (DXCM) started the year trading around US$ 77,77 and today it is at US$ 65,12. Follow the real-time price chart, the historical price of DexCom (DXCM), and stock data from Ibovespa and international markets.

When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

DexCom (DXCM) is it worth it?

Currently, DexCom (DXCM) is priced at US$ 65,12, with a P/E of 42,62%, representing a deviation of 103,60% from its historical average P/E. In the last year, the stock showed a variation of -5.91% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -5,91%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of DexCom (DXCM)?

Investing in stocks of DexCom (DXCM) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -14,32% in the last month, -5,91% in the last year and -33,92% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of DexCom (DXCM) today, the total investment would be US$ 6.512,00, based on the current price of US$ 65,12.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 6.127,14
In 5 years: US$ 4.303,13
In 10 years: 24.009,09

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DXCM

DexCom Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of DXCM

check out the fundamentals of DexCom shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY DexCom

DexCom Inc.

Estados Unidos

26 years

2005

6.400

PROFIT X PRICE DXCM

DXCM results

DXCM cash flow

evolution of assets - DXCM

DXCM balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions